Atom | Advanced Development and Validation of Emerging Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)

Due Dates: April 4, 2025 | October 3, 2025 | December 9, 2025 (final closing)

Funding Amounts: Up to $300,000 per year (direct costs), max 3 years; NIH expects ~10 awards; total program budget $4.3M for FY26.

Summary: Supports advanced development and rigorous validation of novel molecular and cellular analysis technologies to accelerate basic or clinical cancer research.

Key Information: Clinical trials are not allowed; applications must focus on technical innovation, not hypothesis-driven research.

Advanced Development and Validation of Emerging Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)

Sign in to see full grant listing